Nomura Holdings Inc. Has $1.47 Million Position in MetLife, Inc. $MET

Key Points

• Nomura Holdings Inc. increased its stake in MetLife, Inc. by 25.3%, now owning 18,279 shares valued at $1.47 million after purchasing additional shares in the first quarter.
• MetLife recently reported $2.02 EPS for the quarter, missing the consensus estimate of $2.32, with revenue decreasing 2.7% year-over-year.
• The company announced a quarterly dividend of $0.5675 per share, representing an annualized payout of $2.27 with a yield of 2.8%.

Nomura Holdings Inc. increased its stake in MetLife, Inc. (NYSE:MET - Free Report) by 25.3% in the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 18,279 shares of the financial services provider's stock after purchasing an additional 3,692 shares during the quarter. Nomura Holdings Inc.'s holdings in MetLife were worth $1,468,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Csenge Advisory Group lifted its holdings in shares of MetLife by 1.0% during the first quarter. Csenge Advisory Group now owns 13,647 shares of the financial services provider's stock worth $1,096,000 after buying an additional 131 shares during the last quarter. Delta Investment Management LLC lifted its holdings in shares of MetLife by 0.9% during the first quarter. Delta Investment Management LLC now owns 14,265 shares of the financial services provider's stock worth $1,145,000 after buying an additional 133 shares during the last quarter. Stock Yards Bank & Trust Co. lifted its holdings in shares of MetLife by 2.5% during the first quarter. Stock Yards Bank & Trust Co. now owns 6,463 shares of the financial services provider's stock worth $519,000 after buying an additional 159 shares during the last quarter. Unigestion Holding SA lifted its holdings in shares of MetLife by 0.7% during the first quarter. Unigestion Holding SA now owns 23,661 shares of the financial services provider's stock worth $1,900,000 after buying an additional 165 shares during the last quarter. Finally, Davis R M Inc. lifted its holdings in shares of MetLife by 5.3% during the first quarter. Davis R M Inc. now owns 3,315 shares of the financial services provider's stock worth $266,000 after buying an additional 167 shares during the last quarter. 94.99% of the stock is currently owned by institutional investors and hedge funds.

MetLife Stock Performance

MetLife stock opened at $80.58 on Wednesday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.16 and a quick ratio of 0.16. The stock has a fifty day moving average price of $78.22 and a two-hundred day moving average price of $78.40. MetLife, Inc. has a 52-week low of $65.21 and a 52-week high of $89.05. The firm has a market capitalization of $53.59 billion, a P/E ratio of 13.66, a P/E/G ratio of 0.73 and a beta of 0.87.

MetLife (NYSE:MET - Get Free Report) last released its quarterly earnings data on Wednesday, August 6th. The financial services provider reported $2.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.32 by ($0.30). MetLife had a return on equity of 19.88% and a net margin of 5.83%.The company had revenue of $17.34 billion for the quarter, compared to analyst estimates of $18.58 billion. During the same quarter in the prior year, the company earned $2.28 earnings per share. The business's revenue was down 2.7% compared to the same quarter last year. As a group, analysts anticipate that MetLife, Inc. will post 9.65 EPS for the current fiscal year.

MetLife Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 9th. Shareholders of record on Tuesday, August 5th will be paid a dividend of $0.5675 per share. This represents a $2.27 annualized dividend and a yield of 2.8%. The ex-dividend date is Tuesday, August 5th. MetLife's dividend payout ratio is currently 38.47%.

Analyst Ratings Changes

A number of research analysts have recently commented on MET shares. Keefe, Bruyette & Woods cut their price target on MetLife from $94.00 to $92.00 and set an "outperform" rating for the company in a report on Monday, August 11th. Barclays boosted their price objective on MetLife from $88.00 to $94.00 and gave the company an "overweight" rating in a research report on Monday, July 7th. Morgan Stanley lowered their price objective on MetLife from $98.00 to $94.00 and set an "overweight" rating on the stock in a research report on Monday, August 18th. Wall Street Zen cut MetLife from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Finally, UBS Group lowered their price objective on MetLife from $94.00 to $91.00 and set a "buy" rating on the stock in a research report on Thursday, August 7th. Ten research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, MetLife currently has a consensus rating of "Moderate Buy" and a consensus price target of $95.60.

About MetLife

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.